These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4073965)

  • 21. Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?
    Herr HW; Sogani PC
    J Urol; 2001 Oct; 166(4):1296-9. PubMed ID: 11547061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incrusted cystitis after intravesical mitomycin C treatment.
    Llopis M; Moreno J; Botella R; Algado M
    Acta Urol Belg; 1993 Sep; 61(3):21-3. PubMed ID: 8256682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of thiotepa in the treatment of superficial bladder tumors.
    Akdaş A; Kirkali Z; Sengör F; Ilker Y; Taşar C
    Turk J Pediatr; 1984; 26(1-4):243-50. PubMed ID: 6443167
    [No Abstract]   [Full Text] [Related]  

  • 24. [A large amount of distilled water ineffective for prevention of bladder cancer cell implantation at the time of transurethral resection].
    Sakai Y; Fujii Y; Hyochi N; Masuda H; Kawakami S; Kobayashi T; Kageyama Y; Kihara K
    Hinyokika Kiyo; 2006 Mar; 52(3):173-5. PubMed ID: 16617868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiochemotherapy with cisplatin and 5-fluorouracil after transurethral surgery in patients with bladder cancer.
    Weiss C; Engehausen DG; Krause FS; Papadopoulos T; Dunst J; Sauer R; Rödel C
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1072-80. PubMed ID: 17467193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Continuous intravesical instillation of epirubicin immediately after transurethral resection of superficial bladder cancer: a prospective controlled study].
    Maekawa S; Suzuki H; Ohkubo K; Aoki Y; Okada T; Maeda H; Ogura K; Arai Y
    Hinyokika Kiyo; 2000 May; 46(5):301-6. PubMed ID: 10876750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of low grade papillary bladder tumors.
    Herr HW; Donat SM; Reuter VE
    J Urol; 2007 Oct; 178(4 Pt 1):1201-5; discussion 1205. PubMed ID: 17698090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does the management of bladder perforation during transurethral resection of superficial bladder tumors predispose to extravesical tumor recurrence?
    Skolarikos A; Chrisofos M; Ferakis N; Papatsoris A; Dellis A; Deliveliotis C
    J Urol; 2005 Jun; 173(6):1908-11. PubMed ID: 15879773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The role of preserving therapy of invasive cancer of the urinary bladder].
    Matveev BP; Sallum SD; Kamolov BSh; Figurin KM; Matveev VB; Volkova MI
    Urologiia; 2005; (6):3-6. PubMed ID: 16419470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Results of organ-preserving therapy for invasive bladder cancer].
    Matveev BP; Figurin KM; Toktomushev AT
    Urologiia; 2002; (3):3-5. PubMed ID: 12180056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term results of intravesical prevention of recurrence with mitomycin C and adriamycin in patients with superficial bladder cancer].
    Schwaibold H; Klingenberger HJ; Huland H
    Urologe A; 1994 Nov; 33(6):479-83. PubMed ID: 7817443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrency rate influencing effect on intravesical Lycurim treatment in transurethrally resected bladder tumours.
    Kondás J; Szentgyörgyi E
    Ther Hung; 1983; 31(2):55-8. PubMed ID: 6571182
    [No Abstract]   [Full Text] [Related]  

  • 33. [Fluorescent cystoscopy and transurethral electroresection in diagnosis and treatment of patients with invasive cancer of the urinary bladder].
    Komiakov BK; Gorelov SI; Novikov AI; Gorelov AI; Novikov PB; Strokova LA; Al-Atar T
    Urologiia; 2004; (6):37-40. PubMed ID: 15719729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of early intravesical instillation chemotherapy after transurethral resection of the bladder: a prospective evaluation in a consecutive series of 210 cases.
    Engeler DS; Wyler S; Neyer M; Hobi C; Müller J; Schmid HP
    Scand J Urol Nephrol; 2008; 42(6):522-7. PubMed ID: 18609290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vesico-ureteral reflux following transurethral resection of bladder carcinoma].
    Míguez Codesido M; Chantada Abal V; Lancina Martín JA; González Martín M
    Arch Esp Urol; 1984; 37(5):419-24. PubMed ID: 6517627
    [No Abstract]   [Full Text] [Related]  

  • 36. [New therapeutic modalities in invasive bladder tumors].
    Reboul F; Vincent P; Plat F; Smires A; Davin JL; Levallois M
    Pathol Biol (Paris); 1990 Oct; 38(8):808-9. PubMed ID: 2274365
    [No Abstract]   [Full Text] [Related]  

  • 37. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy.
    Herr HW
    J Urol; 2005 Dec; 174(6):2134-7. PubMed ID: 16280743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Drug prevention of recurrence in bladder tumors. Intravesical adriblastin instillation following transurethral resection of non-infiltrating bladder tumors].
    Maier U; Kuber W
    Fortschr Med; 1983 Mar; 101(12):535-40. PubMed ID: 6852720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.